Return On Equity of Zentalis Pharmaceuticals, Inc. from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Zentalis Pharmaceuticals, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • Zentalis Pharmaceuticals, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -51%, a 17% decline year-over-year.
  • Zentalis Pharmaceuticals, Inc. annual Return On Equity for 2024 was -43%, a 32% increase from 2023.
  • Zentalis Pharmaceuticals, Inc. annual Return On Equity for 2023 was -64%, a 11% decline from 2022.
  • Zentalis Pharmaceuticals, Inc. annual Return On Equity for 2022 was -57%, a 17% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Zentalis Pharmaceuticals, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -51% -7.6% -17% 01 Jul 2025 30 Sep 2025
Q2 2025 -52% -7.4% -17% 01 Apr 2025 30 Jun 2025
Q1 2025 -65% -19% -42% 01 Jan 2025 31 Mar 2025
Q4 2024 -43% +21% +32% 01 Oct 2024 31 Dec 2024
Q3 2024 -44% +19% +30% 01 Jul 2024 30 Sep 2024
Q2 2024 -44% +20% +31% 01 Apr 2024 30 Jun 2024
Q1 2024 -46% +9.9% +18% 01 Jan 2024 31 Mar 2024
Q4 2023 -64% -6.6% -11% 01 Oct 2023 31 Dec 2023
Q3 2023 -63% -4.1% -7% 01 Jul 2023 30 Sep 2023
Q2 2023 -64% -17% -37% 01 Apr 2023 30 Jun 2023
Q1 2023 -56% -5.2% -10% 01 Jan 2023 31 Mar 2023
Q4 2022 -57% -8.5% -17% 01 Oct 2022 31 Dec 2022
Q3 2022 -59% -12% -25% 01 Jul 2022 30 Sep 2022
Q2 2022 -47% +11% +19% 01 Apr 2022 30 Jun 2022
Q1 2022 -51% -1.5% -3% 01 Jan 2022 31 Mar 2022
Q4 2021 -49% +6.7% +12% 01 Oct 2021 31 Dec 2021
Q3 2021 -47% +36% +44% 01 Jul 2021 30 Sep 2021
Q2 2021 -58% +1635% +97% 01 Apr 2021 30 Jun 2021
Q1 2021 -49% -152% -148% 01 Jan 2021 31 Mar 2021
Q4 2020 -56% -248% -129% 01 Oct 2020 31 Dec 2020
Q3 2020 -83% 01 Jul 2020 30 Sep 2020
Q2 2020 -1693% 01 Apr 2020 30 Jun 2020
Q1 2020 103% 01 Jan 2020 31 Mar 2020
Q4 2019 192% 01 Oct 2019 31 Dec 2019

Zentalis Pharmaceuticals, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -43% +21% +32% 01 Jan 2024 31 Dec 2024
2023 -64% -6.6% -11% 01 Jan 2023 31 Dec 2023
2022 -57% -8.5% -17% 01 Jan 2022 31 Dec 2022
2021 -49% +6.7% +12% 01 Jan 2021 31 Dec 2021
2020 -56% -248% -129% 01 Jan 2020 31 Dec 2020
2019 192% 01 Jan 2019 31 Dec 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.